title: Prenatal diagnosis and management of congenital adrenal hyperplasia.
abstract: Congenital adrenal hyperplasia is one of a few inherited disorders that can be managed by administering medication to the fetus via oral maternal administration. Dexamethasone given in the first trimester ameliorates genital ambiguity in the affected female fetus. Mother and fetus should be monitored during and after pregnancy for treatment-related complications. Therapy can be coordinated with prenatal diagnostic testing.
authors.affiliation: Division of Pediatric Endocrinology and Metabolism, North Shore University Hospital, Manhasset, New York.
authors.forename: P W
authors.initials: PW
authors.lastname: Speiser
authors.forename: M I
authors.initials: MI
authors.lastname: New
mesh_terms: D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis* / Q000188:drug therapy*; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016903:Drug Monitoring; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011296:Prenatal Diagnosis
chemical_list: D003907:Dexamethasone